Lv41
550 积分 2023-11-01 加入
Distinct prognostic and molecular profiles of fat versus vein invasion in T3a renal cell carcinoma
5小时前
已完结
Atlas of Metastatic Gastric Cancer Links Ferroptosis to Disease Progression and Immunotherapy Response
6个月前
已完结
DIRECT REGRESSION MODELS FOR SURVIVAL PARAMETERS BASED ON PSEUDO-VALUES
10个月前
已完结
Spleen Glucose Metabolism on [18F]-FDG PET/CT for Cancer Drug Discovery and Development cannot be Overlooked
1年前
已完结
Role of 18F-FDG PET/CT in the assessment of therapy response and clinical outcome in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors or immunotherapy
1年前
已关闭
Treatment Selection in First-line Metastatic Renal Cell Carcinoma—The Contemporary Treatment Paradigm in the Age of Combination Therapy
1年前
已完结
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
1年前
已完结
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma
1年前
已完结
Role of 18F-FDG PET/CT in the assessment of therapy response and clinical outcome in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors or immunotherapy
1年前
已关闭
Tranexamic acid for trauma: optimal timing of administration based on the CRASH-2 and CRASH-3 trials
1年前
已完结
皖公网安备34019202002308
